Changes to the 2024 ACIP Adult Immunization Schedule: At-a-Glance

The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has released an updated version of the adult immunization schedule for ages 19 years and older in the US.

In this short slide show you will find highlights of revisions and additions to the Notes section of the 2024 schedule for vaccination against specific diseases including COVID-19, respiratory syncytial virus (RSV), influenza, poliovirus, Mpox, and meningococcal serogroups ABCW&Y.

Adult COVID-19 vaccination
ACIP 2024 updates to recommendations

Adult Hep A, Hep B vaccination
ACIP 2024 updates to recommendations

Adult HPV vaccination
ACIP 2024 updates to recommendations

Adult influenza vaccination
ACIP 2024 updates to recommendations

Adult meningococcal vaccination
ACIP 2024 updates to recommendations

Adult Mpox vaccination
ACIP 2024 updates to recommendations

Adult pneumococcal vaccination
Adult poliovirus vaccination
ACIP 2024 updates to recommendations

Adult RSV vaccination
ACIP 2024 updates to recommendations

---

Source: Murthy N, Wodi AP, McNally VV, Daley MF, Cineas S on behalf of the Advisory Committee on Immunization Practices. Recommended adult immunization schedule, United States, 2024. Ann Intern Med. Published online January 12, 2024. doi:10.7326/M23-3269

PreviousNext

Significant changes have also been made to the schedule's format and graphics including to the Cover page, Table 1. Recommended Adult Immunization Schedule by Age Group, and Table 2. Recommended Adult Immunization Schedule by Medical Condition and Other Indications. Clinicians are referred to the January 12, 2024 issue of the Annals of Internal Medicine for the full document.

This adult immunization schedule is recommended by ACIP and approved by CDC, the American College of Physicians, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, the American College of Nurse-Midwives, the American Academy of Physician Associates, the American Pharmacists Association, and the Society for Healthcare Epidemiology of America.